Welcome to our dedicated page for Pedevco SEC filings (Ticker: PED), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PEDEVCO Corp. filings document the company’s oil and natural gas operations, material events, capital structure, governance, and financing arrangements. Recent disclosures include amendments to credit agreements, borrowing-base mechanics, security-holder rights, preferred stock issued in completed merger transactions, and operating and financial result updates for its Rockies-focused asset base.
The company’s regulatory record also covers shareholder voting matters, governing-document amendments, investor presentation risk factors, and risks associated with exploration, development and production, oil and natural gas prices, environmental regulation, liquidity, debt service, asset integration, and continued NYSE American listing compliance.
PEDEVCO Corp. (PED) director equity grant reported: A reporting person serving as a director of PEDEVCO Corp. disclosed receiving 196,359 shares of restricted common stock on 11/13/2025 under the company’s 2021 Equity Incentive Plan. These shares were issued at a stated price of $0, reflecting compensation rather than a cash purchase.
The restricted shares vest in four equal 25% installments on the three-, six-, nine-, and twelve-month anniversaries of October 31, 2025, subject to continued service and the terms of a Restricted Shares Grant Agreement. The filing notes the grant is exempt from short-swing profit rules under Rule 16b-3, and that, as a designated director of affiliates of Juniper Capital Advisors, L.P., the shares were immediately transferred to Juniper, with the director disclaiming beneficial ownership except for any pecuniary interest.
PEDEVCO Corp. (PED) filed a current report to announce that it has released its financial results for the quarter ended September 30, 2025. The company furnished a press release as Exhibit 99.1, which includes its quarterly performance details and uses certain non-GAAP financial measures, along with reconciliations to comparable GAAP metrics. The report also highlights that the press release contains forward-looking statements subject to risks and uncertainties, and directs readers to the company’s other SEC filings for a fuller discussion of these risk factors.
PEDEVCO Corp (PED) reported a Form 4 showing a director received 114,543 shares of restricted common stock on 11/13/2025. The shares were issued under the company’s 2021 Equity Incentive Plan as consideration for Board service at a stated price of $0.
The award vests in four equal installments: 25% on each of the three-, six-, nine-, and twelve-month anniversaries of October 31, 2025, subject to continued service and the terms of a Restricted Shares Grant Agreement. Following the transaction, the reporting person beneficially owns 114,543 shares direct. The transaction is noted as exempt from Section 16(b) under Rule 16b-3.
PEDEVCO (PED) director Kristel Franklin reported receiving 114,543 shares of restricted common stock on 11/13/2025 under the company’s 2021 Equity Incentive Plan. The filing lists a price of $0, reflecting a stock grant for board services, and shows 114,543 shares beneficially owned following the transaction.
The award vests in four equal 25% tranches on the 3-, 6-, 9-, and 12-month anniversaries of October 31, 2025, contingent on continued service and the grant agreement. The transaction is noted as exempt under Rule 16b-3.
PEDEVCO Corp. (PED) reported Q3 2025 results. Oil and gas sales were $6.961 million, down from $9.050 million a year ago. The quarter showed a net loss of $325,000 versus net income of $2.915 million in Q3 2024. For the nine months, oil and gas sales were $22.669 million versus $28.977 million, with a net loss of $1.861 million versus net income of $6.369 million.
Cash and cash equivalents were $10.922 million, total assets $135.888 million, and shareholders’ equity $115.368 million as of September 30, 2025. Operating cash flow for the nine months was $12.905 million. Shares outstanding were 92,519,352 as of September 30, 2025.
The company restated December 31, 2024 balances, reducing deferred income taxes by $5.496 million and lowering shareholders’ equity by the same amount. PEDEVCO recognized $1.378 million in note receivable credit loss year‑to‑date.
Subsequent events: On October 31, 2025, PEDEVCO closed mergers adding Rockies assets and issued 10,650,000 Series A Preferred that will convert 10‑for‑1 into 106,500,000 common shares after an information statement period. A concurrent PIPE sold 6,363,637 Series A Preferred at $5.50, yielding $35,000,004 net and convertible into 63,636,370 common shares. The company also entered an amended and restated credit facility with a $120 million borrowing base (up to $250 million) maturing in 2029.
PEDEVCO Corp (PED) reported an initial beneficial ownership filing (Form 3) by director Edward Geiser, reflecting indirect holdings of Series A Convertible Preferred Stock through NPOG, COG, and J PED.
The preferred stock automatically converts into common stock at a 10-for-1 ratio on the “Automatic Conversion Date,” which follows a twenty-day Rule 14c-2 period after majority stockholder approval on October 31, 2025. The filing lists 140,227,280 shares of common stock underlying these securities. Mr. Geiser disclaims beneficial ownership beyond his pecuniary interest.
PEDEVCO Corp (PED) filed a Form 3 reporting initial beneficial ownership tied to Series A Convertible Preferred Stock indirectly held through North Peak Oil & Gas Holdings, LLC and Century Oil and Gas Holdings, LLC. The filing lists derivative securities convertible into 62,793,710 shares of common stock.
The Series A Convertible Preferred Stock automatically converts at a 10-for-1 ratio on the “Automatic Conversion Date,” which occurs after a twenty calendar day period following distribution of an information statement under Rule 14c-2. The approval event occurred on October 31, 2025. The Series A preferred has no expiration date. The reporting person disclaims beneficial ownership except to the extent of its pecuniary interest.
PEDEVCO (PED) had an initial statement of beneficial ownership (Form 3) filed. The filing lists derivative holdings of Series A Convertible Preferred Stock representing 37,658,222 shares of common stock underlying.
The Series A preferred automatically converts into common stock at a 10-for-1 ratio after the twenty calendar day period commencing on distribution of an information statement under Rule 14c-2; majority stockholder approval occurred on October 31, 2025. The securities are held of record by North Peak Oil & Gas Holdings, LLC and Century Oil and Gas Holdings, LLC, with beneficial ownership disclaimed except to the extent of pecuniary interest.
PEDEVCO (PED) reporting persons, including Simon Kukes and The SGK 2018 Revocable Trust, reported acquiring 2,801,814 shares of Series A Convertible Preferred Stock on October 31, 2025 (code A). Each preferred share automatically converts into common stock at a 10‑for‑1 ratio on the “Automatic Conversion Date” following distribution of an information statement disclosing majority stockholder approval that occurred on October 31, 2025. The price of the derivative security was $5.5 per preferred share.
The filing also lists common stock beneficial ownership after the reported transactions: 8,121,950 shares held directly, 51,791,325 shares held indirectly through The SGK 2018 Revocable Trust, and 3,000 shares held indirectly by spouse. The trust is shown as holding 2,801,814 preferred shares following the transaction, corresponding to 28,018,140 underlying common shares under the stated conversion ratio.
PEDEVCO (PED) Schedule 13D/A: The SGK 2018 Revocable Trust and Dr. Simon G. Kukes updated their beneficial ownership following the closing of PEDEVCO’s mergers and PIPE financing on October 31, 2025. The SGK Trust reports 51,791,325 shares with shared voting and dispositive power, representing 56.0% of the class, based on 92,519,352 shares outstanding as of November 4, 2025. Dr. Kukes reports 59,936,275 shares (including spouse holdings and options), equal to 64.8% of the class.
The amendment notes issuance of 10,650,000 shares of Series A Convertible Preferred Stock in the mergers and 6,363,637 Series A Preferred in the PIPE at $5.50 per share, with $35,000,004 in net proceeds. Each preferred share converts into 10 common shares after an information statement process under Rule 14c‑2; these conversion shares are not included in the reported beneficial ownership.
Corporate actions include a planned increase in authorized common stock to 300,000,000 and governance provisions tied to the Series A Preferred. Dr. Kukes resigned from the Board effective at closing. The filing also references support and shareholder agreements and future resale registration obligations for conversion shares.